Pharmalink (intellectual property rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Pharmalink (intellectual property rights) General Information

Description

Intellectual property associated with the treatment of post-polio syndrome (PPS). The assets also include US, European and Japanese patents for a specific PPS treatment method. It helps in curing muscle weakness associated with polio infection.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Other Healthcare
Acquirer
Grifols
Primary Office
  • Wallingatan 26B
  • 111 24 Stockholm
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmalink (intellectual property rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmalink (intellectual property rights)‘s full profile, request access.

Request a free trial

Pharmalink (intellectual property rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmalink (intellectual property rights)‘s full profile, request access.

Request a free trial